RELX PLC RELX Q2 2025 Results Exceed Forecasts Key Drivers Inside NFL Urges CFTC to Ban Specific Prediction Market Contracts Citing Integrity Concerns SandRidge Energy SD Slips 135 as Traders Eye Key Support at 1454 Cable One CABO Stalls at 4773 Consolidation Phase 20260520 Analyst Optimism Meets Market Caution NVIDIA Shares Face Selling Pressure Despite 330 Price Targets Arvind Sanger Voices Cautiously Optimistic Outlook on Indian Markets Amid Earnings Revival Hopes AIPowered Job Applications Spark Homogenization and Recruiter Doom Loop Industry Experts Warn Retail Closure Longstanding Chain Shuts Down After 33 Years of Business UK Energy Vulnerability May Require Deeper State Intervention Amid Cost of Living Measures Stocks Surge Amid Strong Earnings and Potential Iran Deal Key Events to Watch ColgatePalmolive Q1 2026 Earnings EPS Slightly Below Estimates Amid Stable Operations INTU Q1 2026 Earnings EPS Just Misses Estimates Amid Solid Business Momentum NEON Q1 2026 Earnings Earnings Miss as Revenues Remain Undisclosed RDN Q1 2026 Earnings EPS Beat Sends Stock Lower Despite Positive Surprise PNR Q1 2026 Earnings EPS Surpasses Estimates Shares Edge Higher MKTW Q1 2026 Earnings Massive EPS Miss Signals Challenges Ahead Crown Reserve Acquisition Corp I Unit CRACU Holds Steady at 1022 Amid Limited Trading Activity Sharplink Inc SBET Declines 386 as Stock Nears Key Support at 592 Denali Therapeutics DNLI Gains 387 as Stock Nears Key Resistance Level AA Mission Acquisition Corp II YCY Holds Steady at 1016 SPAC Continues Trading Near Trust Value GormanRupp GRC Gains 227 as Strong Volume Lifts Stock Toward Key Resistance iOThree Limited IOTR Declines 385 as Stock Tests Key Support at 19 Ceragon Networks CRNT Gains 325 as Stock Pushes Toward Key Resistance at 30 PLBY Retreats to 128 Bearish Momentum Tests Critical Support KB Home KBH Holds Near Support Amid Low Volume Drift Upwork Inc UPWK Sees Gains as Freelance Platform Tests Key Resistance What SP SPGIs Flat Price Action at 41388 Is Telling Us 20260527 Oppenheimer Maintains Outperform Rating on Gain Therapeutics Signaling Continued Confidence KW Q1 2026 Earnings Strong EPS Beat Surprises Market Vor Biopharma Surges 546 as Buyers Defend Key Support Level VOR